CPHA Canvax


November 24, 2021
Duration: 1 hour 

Presentation highlights: 

  • To provide an overview of the Pfizer-BioNTech vaccine for children 5-11 years of age and its use and administration, as well as timing of the concurrent vaccination programs this fall and winter. 
  • To share evidence and information on the management of vaccination pain and fear in children.
  • To provide models for the operations of immunization clinics and considerations for their use. 


  • Katie Rutledge-Taylor, RN, BScN, MPH, Public Health Agency of Canada


  • Dr. Bryna Warshawsky, MDCM, MHSc, FRCPC, Public Health Agency of Canada
  • Dr. Kathryn Birnie, PhD, RPsych, University of Calgary, SKIP
  • Alexandra Nunn, RN, MPH, Public Health Agency of Canada
Rating See Comments Ratings



Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.